Silicon Laboratories (NASDAQ:SLAB – Get Free Report) updated its first quarter 2025 earnings guidance on Tuesday. The company provided earnings per share guidance of -0.190-0.010 for the period, compared to the consensus earnings per share estimate of -0.080. The company issued revenue guidance of $170.0 million-$185.0 million, compared to the consensus revenue estimate of $175.6 million.
Wall Street Analysts Forecast Growth
A number of brokerages have commented on SLAB. KeyCorp upped their price objective on Silicon Laboratories from $115.00 to $160.00 and gave the company an “overweight” rating in a report on Wednesday, January 22nd. Morgan Stanley decreased their price objective on Silicon Laboratories from $123.00 to $97.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 5th. Barclays upped their target price on Silicon Laboratories from $75.00 to $120.00 and gave the company an “equal weight” rating in a research report on Friday, January 17th. Stifel Nicolaus upped their target price on Silicon Laboratories from $135.00 to $145.00 and gave the company a “buy” rating in a research report on Monday, January 6th. Finally, Susquehanna assumed coverage on Silicon Laboratories in a research report on Tuesday, December 17th. They set a “neutral” rating and a $130.00 target price for the company. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, Silicon Laboratories presently has a consensus rating of “Hold” and a consensus target price of $133.56.
Get Our Latest Stock Analysis on SLAB
Silicon Laboratories Trading Down 1.1 %
Silicon Laboratories (NASDAQ:SLAB – Get Free Report) last announced its earnings results on Monday, November 4th. The semiconductor company reported ($0.13) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.20) by $0.07. The company had revenue of $166.00 million for the quarter, compared to analysts’ expectations of $165.50 million. Silicon Laboratories had a negative return on equity of 12.60% and a negative net margin of 46.93%. Silicon Laboratories’s quarterly revenue was down 18.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.48 earnings per share. As a group, analysts expect that Silicon Laboratories will post -3.56 earnings per share for the current year.
Insiders Place Their Bets
In other Silicon Laboratories news, Director William G. Bock sold 2,000 shares of the business’s stock in a transaction on Wednesday, January 22nd. The stock was sold at an average price of $140.77, for a total value of $281,540.00. Following the transaction, the director now owns 32,115 shares of the company’s stock, valued at approximately $4,520,828.55. The trade was a 5.86 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.72% of the company’s stock.
About Silicon Laboratories
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Further Reading
- Five stocks we like better than Silicon Laboratories
- Stock Market Upgrades: What Are They?
- Palantir Stock Surges After Blockbuster Earnings: What’s Next?
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- 2 Solar Stocks Heating Up for a Major Industry Rebound
- 3 Monster Growth Stocks to Buy Now
- Gold Stocks Shine as Prices Hit Record Highs—Top 3 Picks
Receive News & Ratings for Silicon Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silicon Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.